Skip to content
Search AI Powered

Latest Stories

'Allergies not linked to mental health traits'

Allergic diseases such as asthma, atopic dermatitis and hay fever do not cause the onset of mental health conditions or vice versa, according to the findings of a new University of Bristol-led study.

The results of the study were published on Tuesday (October 6) in the journal 'Clinical and Experimental Allergy'.


While previous studies have reported an observational relationship between mental health and common allergic diseases, until now, causal relationships had not yet been identified.

Researchers from Bristol Medical School investigated whether allergic diseases actually cause mental health traits including anxiety, depression, bipolar disorder and schizophrenia or vice-versa.

First, they sought to isolate the effects of these allergic diseases by applying a scientific technique called 'mendelian randomisation', which allowed them to identify genetic variants linked to these allergic diseases and then investigated how these variants were causally related to the presence of mental health conditions based on a sample of 12,000-344,901 individuals.

Although researchers identified observational associations between allergic disease and mental health traits, these were not replicated in the team's causal analysis.

Little evidence of a causal relationship between the onset of allergic disease and mental health was found, suggesting that the observational associations found were due to confounding or other forms of bias.

The authors conclude that intervening on the initial presentation of allergic disease is unlikely to improve mental health outcomes. Likewise, preventing the onset of mental health traits will unlikely reduce the risk of allergic disease.

However, further research is required to investigate whether intervening on the progression of allergic disease after onset has any causal impact on mental health.

Dr Ashley Budu-Aggrey, senior research associate and the study's lead author said: "Common mental health disorders such as anxiety and depression are some of the largest contributors to the global burden of disease and the prevalence of these and allergic disease has been increasing for some time.

Disentangling the nature of the relationship between allergic disease and mental health helps answer an important health question and suggests that the onset of allergic disease does not cause the onset of mental health traits or vice versa."

According to added Dr Budu-Aggrey this does not rule out a potential causal effect upon the progression of disease which is yet to be investigated and could help uncover novel treatment strategies for allergic disease or mental health traits.

Senior author Dr Hannah Sallis added: "The research used a combination of approaches and data from several studies.

"This helps to strengthen our confidence in the findings. Establishing whether allergic disease causes mental health problems, or vice versa, is important to ensure that resources and treatment strategies are targeted appropriately."

More For You

Cargo plane unloading pharmaceuticals at US airport amid tariff concerns and stockpiling

Imports jumped in particular from Ireland, the top drug exporter to the US

Pic credit: iStock

Pharma imports to US surged in March as drugmakers look to avoid tariffs

Pharmaceutical imports to the US surged in March as drugmakers stocked up ahead of potential US tariffs on their products, which have historically been exempt from such fees.

Total imports of pharmaceutical products exceeded $50 billion in the month - the equivalent of 20 per cent of all pharmaceutical imports in 2024, according to data from a U.S. Commerce Department report on Tuesday.

Keep ReadingShow less
Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less